Effect on Phosphodiesterase and cAMP Accumulation
The molecular action of caffeine is based on its ability to act as a competitive inhibitor of the enzyme phosphodiesterase (PDE). Under normal physiological conditions, this enzyme is responsible for the degradation of cyclic adenosine monophosphate (cAMP).
The reaction blocked by caffeine is: cAMP $\xrightarrow{\text{PDE}}$ AMP.
Due to PDE inhibition, cAMP breakdown halts, and its intracellular concentration rapidly increases. It is important to distinguish this target from other enzymes: caffeine specifically blocks PDE, rather than adenylate cyclase, guanylate cyclase, or acetylcholinesterase.
Activation of Protein Kinase A (PKA)
Accumulated cAMP acts as a potent secondary messenger. Its primary role in this pathway is the activation of the enzyme Protein Kinase A (PKA).
In its inactive state, a PKA molecule is a complex composed of four subunits:
- Two regulatory (R) subunits
- Two catalytic (C) subunits
When intracellular cAMP levels rise, these messenger molecules bind tightly to the regulatory subunits. This leads to the dissociation (breakdown) of the enzyme complex, releasing active catalytic subunits of PKA capable of phosphorylating other target proteins.
Metabolic Cascade: Glycogenolysis and Lipolysis
The released catalytic subunits of active Protein Kinase A trigger a phosphorylation cascade, activating key enzymes of energy metabolism. The primary pathways stimulated are:
- Glycogenolysis (breakdown of intracellular glycogen)—leads to a rapid increase in glucose levels.
- Lipolysis (breakdown of fats)—ensures the release of additional energy.
Complete Reaction Cascade:
- Competitive inhibition of PDE $\rightarrow$ sharp increase in [cAMP] concentration.
- Accumulation of [cAMP] $\rightarrow$ activation of Protein Kinase A.
- Active Protein Kinase A $\rightarrow$ phosphorylation (and activation) of phosphorylase kinase.
- Active phosphorylase kinase $\rightarrow$ phosphorylation (and activation) of glycogen phosphorylase.
- Active glycogen phosphorylase $\rightarrow$ intensive glycogen breakdown.
Related Drugs (PDE Inhibitors)
The pharmacologic class of phosphodiesterase inhibitors includes more than just caffeine. In clinical practice, drugs with a similar primary mechanism of action but tailored therapeutic effects are widely used:
- Pentoxifylline—used to improve blood rheology (decreases blood viscosity).
- Theophylline—used to relax bronchial smooth muscle and effectively relieve bronchospasm.